Vanguard Group Inc Blueprint Medicines Corp Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Vanguard Group Inc holds 6,640,523 shares of BPMC stock, worth $860 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,640,523
Previous 6,774,884 1.98%
Holding current value
$860 Million
Previous $591 Million 0.53%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$86.69 - $115.63 $11.6 Million - $15.5 Million
-134,361 Reduced 1.98%
6,640,523 $588 Million
Q4 2024

Feb 11, 2025
BUY
$82.48 - $101.39 $7.54 Million - $9.27 Million
91,450 Added 1.37%
6,774,884 $591 Million
Q3 2024

Nov 13, 2024
BUY
$84.1 - $120.5 $12.2 Million - $17.5 Million
144,968 Added 2.22%
6,683,434 $618 Million
Q2 2024

Aug 13, 2024
BUY
$85.18 - $108.78 $19.5 Million - $24.9 Million
228,489 Added 3.62%
6,538,466 $705 Million
Q1 2024

May 10, 2024
BUY
$73.17 - $99.79 $14.3 Million - $19.5 Million
195,007 Added 3.19%
6,309,977 $599 Million
Q4 2023

Feb 14, 2024
BUY
$43.96 - $92.84 $6.5 Million - $13.7 Million
147,827 Added 2.48%
6,114,970 $564 Million
Q3 2023

Nov 14, 2023
BUY
$46.9 - $66.0 $1.77 Million - $2.49 Million
37,716 Added 0.64%
5,967,143 $300 Million
Q2 2023

Aug 14, 2023
BUY
$42.2 - $66.37 $2.13 Million - $3.35 Million
50,483 Added 0.86%
5,929,427 $375 Million
Q1 2023

May 15, 2023
BUY
$37.97 - $50.0 $3.97 Million - $5.22 Million
104,488 Added 1.81%
5,878,944 $264 Million
Q4 2022

Feb 10, 2023
BUY
$41.06 - $66.48 $4.65 Million - $7.54 Million
113,353 Added 2.0%
5,774,456 $253 Million
Q3 2022

Nov 14, 2022
BUY
$49.93 - $77.7 $2.21 Million - $3.44 Million
44,292 Added 0.79%
5,661,103 $373 Million
Q2 2022

Aug 12, 2022
BUY
$45.23 - $70.15 $4.15 Million - $6.44 Million
91,751 Added 1.66%
5,616,811 $284 Million
Q1 2022

May 13, 2022
SELL
$54.1 - $110.08 $471,265 - $958,906
-8,711 Reduced 0.16%
5,525,060 $353 Million
Q4 2021

Feb 14, 2022
SELL
$94.25 - $115.99 $4.65 Million - $5.73 Million
-49,361 Reduced 0.88%
5,533,771 $593 Million
Q3 2021

Nov 12, 2021
BUY
$80.98 - $109.47 $1.42 Million - $1.93 Million
17,589 Added 0.32%
5,583,132 $574 Million
Q2 2021

Aug 13, 2021
BUY
$82.78 - $101.0 $461 Million - $562 Million
5,565,543 New
5,565,543 $490 Million

Others Institutions Holding BPMC

# of Institutions
379
Shares Held
67.9M
Call Options Held
1.54M
Put Options Held
1.21M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $7.73B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email